Cardiovascular risk factors in 116 patients 5 years or more after liver transplantation

We assessed the cardiovascular risk factors (CVRFs) in 116 stable liver transplant patients surviving for 5 years of more (median: 102 months). The prevalence of smokers was 29.3%, hypertension 49.1%, obesity 22.4%, hypercholesterolemia 34.5%, hypertriglyceridemia 11.2%, and hyperhomocysteinemia 57.8%. Diabetes was found in 21.5% of the patients, being more frequent in patients with hepatitis-C-virus infection (31.8% vs 15.3%; P= 0.03). Patients on cyclosporine therapy had a higher prevalence of hypertension, hypercholesterolemia and hyperthomocysteinemia than those treated with tacrolimus. Multivariate analysis showed only an association between cyclosporine therapy and cholesterol concentrations (odds ratio: 1.02; 95% confidence interval (CI): 1.00–1.03; P= 0.01). The prevalence of hypertension, diabetes, hypercholesterolemia and hypertriglyceridemia was lower at the time of the study than at 1 and 3 years after transplantation (P<0.05), probably related to steroid withdrawal. Comparing 87 patients CVRFs with the general Spanish population, we found that the age-gender standardized prevalence ratio was not different: smoking 1.46 (95% CI: 0.88–1.76), obesity 1.16 (95% CI: 0.60–1.44), hypertension 1.55 (95% CI: 0.98–1.81), and hypercholesterolemia 0.64 (95% CI: 0.35–1.90). We conclude that the prevalence of CVRFs in liver transplant patients after 5 years or more is lower that found in the first years after the transplantation, and no different from that found within the Spanish population.